Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

China Pharma Holdings (CPHI) Other Operating Expenses: 2010-2024

Historic Other Operating Expenses for China Pharma Holdings (CPHI) over the last 15 years, with Dec 2024 value amounting to $534,526.

  • China Pharma Holdings' Other Operating Expenses fell 22.27% to $103,343 in Q3 2025 from the same period last year, while for Sep 2025 it was $467,982, marking a year-over-year decrease of 25.36%. This contributed to the annual value of $534,526 for FY2024, which is 30.09% down from last year.
  • As of FY2024, China Pharma Holdings' Other Operating Expenses stood at $534,526, which was down 30.09% from $764,571 recorded in FY2023.
  • Over the past 5 years, China Pharma Holdings' Other Operating Expenses peaked at $2.3 million during FY2020, and registered a low of $534,526 during FY2024.
  • Its 3-year average for Other Operating Expenses is $758,344, with a median of $764,571 in 2023.
  • Data for China Pharma Holdings' Other Operating Expenses shows a maximum YoY plummeted of 87.97% (in 2020) over the last 5 years.
  • Yearly analysis of 5 years shows China Pharma Holdings' Other Operating Expenses stood at $2.3 million in 2020, then crashed by 46.80% to $1.2 million in 2021, then fell by 21.28% to $975,934 in 2022, then declined by 21.66% to $764,571 in 2023, then slumped by 30.09% to $534,526 in 2024.